Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (491-500 of 777) with videos related to

Pageof 78
Sort By:
JHEP Reports : Innovation in Hepatology|December 21, 2023
Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortalityLukas Hartl, Benedikt Simbrunner, Mathias Jachs, et al.
United European Gastroenterology Journal|October 31, 2019
Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver diseaseKatharina Staufer, Emina Halilbasic, Walter Spindelboeck, et al.
Gastrointestinal Endoscopy|June 2, 2026
Corrigendum to "Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last 2 decades." Gastrointest Endosc 2025;102:733-7Nikolaus Pfisterer, Florian Riedl, Michael Schwarz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 5, 2020
Epidemiological trends in HCV transmission and prevalence in the Viennese HIV+ populationCaroline Schmidbauer, David Chromy, Victor Schmidbauer, et al.
Journal of Viral Hepatitis|September 5, 2022
HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemicLukas Hartl, Mathias Jachs, David Bauer, et al.
United European Gastroenterology Journal|November 23, 2017
Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinomaMatthias Pinter, Arndt Weinmann, Marcus-Alexander Wörns, et al.
Gastrointestinal Endoscopy|May 5, 2025
Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last 2 decadesNikolaus Pfisterer, Florian Riedl, Michael Schwarz, et al.
Frontiers in Immunology|January 10, 2022
The Tyrosine Kinase Tec Regulates Effector Th17 Differentiation, Pathogenicity, and Plasticity in T-Cell-Driven Intestinal InflammationLisa Sandner, Marlis Alteneder, Ci Zhu, et al.
Journal of Hepatology|February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive ratsPhilipp Schwabl, Berit A Payer, Jelena Grahovac, et al.
Wiener Klinische Wochenschrift|June 20, 2018
Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic functionBernhard Scheiner, Paul René Stammet, Sebastian Pokorny, et al.
Pageof 78

Showing results (491-500 of 777) with videos related to

Sort By:
Pageof 78
JHEP Reports : Innovation in Hepatology|December 21, 2023
Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortalityLukas Hartl, Benedikt Simbrunner, Mathias Jachs, et al.
United European Gastroenterology Journal|October 31, 2019
Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver diseaseKatharina Staufer, Emina Halilbasic, Walter Spindelboeck, et al.
Gastrointestinal Endoscopy|June 2, 2026
Corrigendum to "Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last 2 decades." Gastrointest Endosc 2025;102:733-7Nikolaus Pfisterer, Florian Riedl, Michael Schwarz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 5, 2020
Epidemiological trends in HCV transmission and prevalence in the Viennese HIV+ populationCaroline Schmidbauer, David Chromy, Victor Schmidbauer, et al.
Journal of Viral Hepatitis|September 5, 2022
HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemicLukas Hartl, Mathias Jachs, David Bauer, et al.
United European Gastroenterology Journal|November 23, 2017
Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinomaMatthias Pinter, Arndt Weinmann, Marcus-Alexander Wörns, et al.
Gastrointestinal Endoscopy|May 5, 2025
Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last 2 decadesNikolaus Pfisterer, Florian Riedl, Michael Schwarz, et al.
Frontiers in Immunology|January 10, 2022
The Tyrosine Kinase Tec Regulates Effector Th17 Differentiation, Pathogenicity, and Plasticity in T-Cell-Driven Intestinal InflammationLisa Sandner, Marlis Alteneder, Ci Zhu, et al.
Journal of Hepatology|February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive ratsPhilipp Schwabl, Berit A Payer, Jelena Grahovac, et al.
Wiener Klinische Wochenschrift|June 20, 2018
Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic functionBernhard Scheiner, Paul René Stammet, Sebastian Pokorny, et al.
Pageof 78